Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39493
NL-OMON39493
Completed
Phase 3

ong-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label study - Longheva

Academisch Medisch Centrum0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions1002765510014523venous thrombosis / clot

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
10027655
Sponsor
Academisch Medisch Centrum
Enrollment
10
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
November 15, 2013
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with cancer and confirmed PE or DVT of the leg who have been treated for minimally 6 and maximally 12 months with therapeutic doses of anticoagulants, i.e. LMWH or VKA or a new anticoagulant in a trial
  • •2\. Written informed consent
  • •3\. Indication for long\-term anticoagulant therapy (e.g. because of metastasized disease, chemotherapy)

Exclusion Criteria

  • •1\.\* 18 years of age or below the legal age of consent as per country specific regulations
  • •2\. Indications for anticoagulant therapy other than DVT or PE
  • •3\. Any contraindication listed in the local labeling of enoxaparin, dalteparin, tinzaparin, nadroparin, warfarin, acenocoumarol or fenprocoumon
  • •4\. Childbearing potential without proper contraceptive measures, pregnancy or breastfeeding
  • •5\. Life expectancy of less than 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Selecting cancer patients for treatment using Tumor Organoids, the SENSOR study
NL-OMON46891ederlands Kanker Instituut61
Completed
Not Applicable
MEDIASTINAL STAGING OF NON SMALL CELL LUNG CANCER BY ENDOBRONCHIAL AND ENDOSCOPIC ULTRASONOGRAPHY WITH OR WITHOUT ADDITIONAL SURGICAL MEDIASTINOSCOPY (MEDIASTrial)
NL-OMON52981Maxima Medisch Centrum356
Completed
Phase 4
ong-term follow-up and cross-over of treatment with high-density micropulse laser and half-dose photodynamic therapy in participants of the PLACE trial for chronic central serous chorioretinopathy.Chronic central serous chorioretinopathy10047060
NL-OMON40728eids Universitair Medisch Centrum92
Completed
Not Applicable
A multicentre Prospective study in pAtients undergoing ventral herNia repair by open approach with intrA-peritoneal positioning using parietex* Composite vEntral pAtch.hernia / abdominal wall defect10041297
NL-OMON40149Covidien8
Completed
Not Applicable
An open-label, adaptive multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of RO7234292 in csf and plasma, and safety and tolerability following intrathecal administration in patients with Huntington's disease.Chronic Progressive Choreadegenerative chorea1002929910029317
NL-OMON49037Hoffmann-La Roche4